The effects of ferroptosis accompanied by elevated ROS, intracellular ferrous iron, MDA, and GSH levels, as well as the involvement of the GPX4/TFRC/Ferritin axis mediated by miRNAs, were already reported as antiproliferative strategies in CRC [59,60]. The gene discussed is TFRC; the disease is colorectal carcinoma.